The purpose of this study is to characterize the removability of the Attain StarFix® Model 4195 Left Ventricular (LV) Lead (StarFix®). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food and Drug Administration (FDA) as a condition of approval for the Attain StarFix® Model 4195 LV Lead.
Study Type
OBSERVATIONAL
Enrollment
227
Removal of a LV lead using any tools \& techniques.
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Burbank, California, United States
Removal success of LV leads implanted for more than 180 days
Time frame: More than 180 days post-implant
Success of lead removal by how long the lead has been implanted
Time frame: More than 180 days post-implant
Adverse Events that are related to the LV lead, the extraction procedure, or the extraction tool.
Time frame: 0 to 45 days post-lead extraction
Removal success of Medtronic Model 4195 LV Leads implanted for 90-180 days
Time frame: 90 -180 days post-implant
Summary of tools & techniques used to remove LV leads.
Time frame: More than 180 days post-implant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Long Beach, California, United States
Unnamed facility
Aurora, Colorado, United States
Unnamed facility
Miami, Florida, United States
Unnamed facility
Chicago, Illinois, United States
Unnamed facility
Kansas City, Kansas, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Boston, Massachusetts, United States
Unnamed facility
Saint Paul, Minnesota, United States
...and 14 more locations